Abstract Details

Title A Randomized Double-Blind Placebo- and Positive-Controlled Crossover Study to Evaluate the Effects of Single Doses of SD-809 (Deutetrabenazine) and Tetrabenazine on the Corrected QT Interval

Topic Movement Disorders

Presentation(s) (-)

Poster/Presentation
Number 347

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
David A. Stamler, MD (Alterity Therapeutics) PRESENTER	Dr. Stamler has received personal compensation for serving as an employee of Alterity Therapeutics. Dr. Stamler has stock in Alterity Therapeutics.
	No disclosure on file
	No disclosure on file
Lisa De Boer	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��